AI-powered brain monitoring is helping psychiatry shift from reactive care to proactive intervention.
As featured in IEEE Spectrum, Professor Christopher Rozell's AI model identifies signs of depression relapse five weeks before symptoms appear. The system has uncovered a neural biomarker linked to both relapse and sleep quality, giving clinicians a valuable early warning signal.
This is one of many exciting developments in deep brain stimulation for treatment-resistant depression that are helping turn research into real-world tools for mental health care.
Dan Watson